Literature DB >> 455307

Time-temperature relationship th hyperthermic treatment of malignant and normal tissue in vivo.

J Overgaard, H D Suit.   

Abstract

The effect of hyperthermia on normal and tumor tissue was studied following water bath heating of a methylcholanthrene-induced fibrosarcoma (FSaI) isotransplanted into the feet of C3H mice. The time-temperature relation for the 50% tumor control dose over the temperature range of 41.5--45.5 degrees showed a log linear relationship which followed a biphasically modified Arrhenius plot. At temperatures above 43 degrees, there was a 50% reduction in heating time to obtain the 50% tumor control dose for each 1 degree increase in temperature, corresponding to an activation energy of 140 kcal/mol. At temperatures below 43 degrees, the curve was steeper, with a tendency to double the treatment time for each 0.5 degree reduction in temperature (activation energy, approximately 230kcal/mol). Normal tissue damage in the tumor-bearing foot was estimated at two levels with a 50% response dose assay. Severe normal tissue damage showed a time-temperature relationship similar to the tumor response, thus indicating no variation in therapeutic ratio at different temperatures. However, for slight tissue damage, the therapeutic ratio increased with decreasing temperatures, yielding a better therapeutic ratio at lower temperatures. The time-temperature relationship obtained in the FSaI fibrosarcoma is supported by other studies and points to a general time-temperature relationship for hyperthermic tumor destruction.

Entities:  

Mesh:

Year:  1979        PMID: 455307

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Development of a highly efficient implanted thermal ablation device: in vivo experiment in rat liver.

Authors:  H Matsui; M Hamuro; K Nakamura; H Kayahara; K Murano; Y Kotsuka; Y Miki
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

Review 2.  Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery.

Authors:  Challa S S R Kumar; Faruq Mohammad
Journal:  Adv Drug Deliv Rev       Date:  2011-04-05       Impact factor: 15.470

3.  Application of invasive microwave hyperthermia for the treatment of gliomas.

Authors:  H L Wen; J S Dahele; Z D Mehal; W H Chan; D Y Wen
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

4.  Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.

Authors:  W F Mieler
Journal:  Trans Am Ophthalmol Soc       Date:  1997

5.  Biomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy.

Authors:  Kannan M Krishnan
Journal:  IEEE Trans Magn       Date:  2010-07-01       Impact factor: 1.700

6.  Focal hyperthermia produces progressive tumor necrosis independent of the initial thermal effects.

Authors:  Mehrdad Nikfarjam; Caterina Malcontenti-Wilson; Christopher Christophi
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

7.  Monitoring nanoparticle-mediated cellular hyperthermia with a high-sensitivity biosensor.

Authors:  Amarnath Mukherjee; Mark Castanares; Mohammad Hedayati; Michele Wabler; Bruce Trock; Prakash Kulkarni; Ronald Rodriguez; Robert H Getzenberg; Theodore L DeWeese; Robert Ivkov; Shawn E Lupold
Journal:  Nanomedicine (Lond)       Date:  2014-12       Impact factor: 5.307

Review 8.  Cooling and hemodynamic management in heatstroke: practical recommendations.

Authors:  Abderrezak Bouchama; Mohammed Dehbi; Enrique Chaves-Carballo
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  Importance of preheating temperature and time for the induction of thermotolerance in a solid tumour in vivo.

Authors:  O S Nielsen; J Overgaard
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

10.  Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo.

Authors:  Rui Yang; YanLi An; FengQin Miao; MengFei Li; PeiDang Liu; QiuSha Tang
Journal:  Int J Nanomedicine       Date:  2014-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.